Purpose: Production of the proinflammatory cytokine interleukin (IL) 1α, which is stored in keratinocytes (KCs) and is multifunctional, may be enhanced by glucocorticoids. A study was made to confirm whether immunosuppressants such as the macrocyclic lactone FK506 (tacrolimus) possibly serve to modulate glucocorticoid- stimulated IL-1α production from chemically treated KCs. Methods: Usingcultured human KCs, the effects of FK506 on the production of IL-1α treated with chemicals (trinitrobenzene sulfonic acid sodium salt, TNBS) plus hydrocortisone were analyzed by ELISA and mRNA expression of IL-1α using RT-PCR. Results: Intracellular IL-1α in TNBS-treated human KCs was increased with a low concentration of 10–10M of hydrocortisone. Further FK506 application inhibited significantly this increased production.The mRNA expression of IL-1α at various concentrations of chemicals was not remarkably different. Conclusions: FK506may control the increase in IL-1α with glucocorticoid in KCs, suggesting FK506 to suppress harmful effects of glucocorticoids such as steroid rosacea.